Dr. Simpson, MB, is a Berkeley Impact Fellow, UC Berkeley School of Public Health. A nationally recognized health policy researcher and pediatrician, she is a passionate advocate for the translation of research into policy and practice. Her research focuses on improving the performance of the health care system and includes studies of the quality and safety of care, health and health care disparities and the health policy and system response to childhood obesity. Dr. Simpson has published over 80 articles and commentaries in peer reviewed journals.

Dr. Simpson was Director of the Child Policy Research Center at Cincinnati Children's Hospital Medical Center and professor of pediatrics in the Department of Pediatrics, University of Cincinnati. She served as the Deputy Director of the Agency for Healthcare Research and Quality from 1996 to 2002. Dr. Simpson serves on the Robert Wood Johnson Clinical Scholars Program and Health Policy Scholars Program National Advisory Councils, and the Editorial boards for the Journal of Comparative Effectiveness Research and Frontiers in Public Health Systems and Services Research. In October 2013, Dr. Simpson was elected to the Institute of Medicine.

Dr. Simpson earned her undergraduate and medical degrees at Trinity College (Dublin, Ireland), a master’s in public health at the University of Hawaii, and completed a post-doctoral fellowship in health services research and health policy at the University of California, San Francisco. She was awarded an honorary Doctor of Science degree by the Georgetown University School of Nursing and Health Studies in 2013.

Dr. Simpson's areas of expertise include translating research into policy; quality and safety of health care; health and health care disparities; childhood obesity; and child health services.

Dylan H. Roby, PhD, is Associate Chair and Associate Professor in the Department of Health Policy and Management at the University of Maryland School of Public Health. His research focus is on Medicaid, community health centers, safety net hospitals, delivery system change, and the Affordable Care Act's implications for insurance markets, system redesign and access to care. He teaches courses on health politics and policy in the MHA, MPH and PhD programs in the department. Roby collaborates with colleagues at UC Berkeley and UCLA on the California Simulation of Insurance Markets (CalSIM) microsimulation model (www.calsim.org), which he helped develop over the past decade, and is a member of the cost analysis team for the California Health Benefit Review Program (www.chbrp.org). Although his primary academic appointment is in the University of Maryland's School of Public Health, he is a faculty associate with the UCLA Center for Health Policy Research and an adjunct associate professor of health policy and management at UCLA. Dr. Roby has been interviewed and quoted by various media outlets, including the Los Angeles Times, New York Times, CNN, Fox News, Al Jazeera America, Cosmopolitan, CBS radio, and NPR-affiliates including KPCC, WAMU, Wisconsin Public Radio, and KQED.

As the former director (2012-2014) of the Health Economics and Evaluation Research Program at the UCLA Center for Health Policy Research, Dr. Roby helped developed the Center's capacity for analysis of Medicaid claims data, Medicaid waiver evaluation, and conducting confidential data analyses and surveys. He served as the associate director of the UCLA MPH Program in Health Policy and Management from 2010-2012. Prior to becoming the director of Health Economics and Evaluation Research, he was a senior researcher at the Center from 2003 to 2011. Prior to that, Dr. Roby worked for four years as a senior research associate at The George Washington University Center for Health Services Research and Policy. He worked on safety net issues, including data analysis and research on community health centers and public hospitals. During his first stint in Washington, DC, he also worked for the National Association of Community Health Centers, the National Governors' Association's Center for Best Practices, and the Progressive Policy Institute. Prior to that, he was a research assistant at the UCLA Center for Health Policy Research.

Roby graduated from UCLA with a bachelor's degree in geography and a minor in public policy. He earned his doctoral degree in public policy from The George Washington University.

Michael is global co-head of the Office of Government Affairs. He joined Goldman Sachs as a managing director in 2009.

Prior to joining the firm, Michael was executive vice president for Global Advocacy at the Securities Industry and Financial Markets Association (SIFMA), where he was responsible for global legal, governmental, and legislative affairs and advocacy initiatives. Previously, he was Deputy Staff Director of the US House Financial Services Committee and he also had joint responsibility for Committee policy related to the banking, securities and insurance industries.

Earlier in his career, Michael worked at Mercantile Bankshares Corporation, where he held several senior positions, including executive vice president and chief administrative officer. Before joining Mercantile, he held the position of Senior Minority Counsel with the House Financial Services Committee. Michael has also held positions at JPMorgan Chase & Co. and was an associate at Davis Polk & Wardwell with the financial institutions practice.

Michael earned a BA from Notre Dame and a JD from Notre Dame Law School.

Dr. Onukwugha’s research interests are in cost-effectiveness analysis, health disparities, and medical decision-making by individuals. Her research on the costs and causes of discharges against medical advice was supported by a K12 grant (Alan Shuldiner, Principal Investigator, NIH 1K12RR023250-01). She examines the costs and outcomes associated with transitional care, medication use, and hospital discharge disposition. Dr. Onukwugha received her PhD in Economics from Virginia Tech. She completed a Post-Doctoral Fellowship in Pharmacoeconomics at the University of Maryland and was the recipient of the 2005 Post-Doctoral Fellowship in Health Outcomes from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.

Sharyl Nass, Ph.D. is Director of the Board on Health Care Services and Director of the National Cancer Policy Forum at the National Academies of Sciences, Engineering, and Medicine. The Board’s activities pertain to the organization, financing, effectiveness, workforce, and delivery of health care. The Cancer Forum examines policy issues pertaining to the entire continuum of cancer research and care. For more than 15 years, Dr. Nass has worked on a broad range of health policy topics that includes the quality and safety of care, clinical trials, oversight of health research, developing biomarkers and omics-based tests to guide patient care, technologies and quality standards for breast imaging, strategies for large-scale biomedical science, and contraceptive research and development. With a Ph.D. in cell and tumor biology from Georgetown University and postdoctoral training at the Johns Hopkins University School of Medicine, she has published papers on the cell and molecular biology of breast cancer. She also holds a BS in genetics and an MS in Endocrinology/Reproductive Physiology, both from the University of Wisconsin-Madison. In addition, she studied developmental genetics and molecular biology at the Max Planck Institute in Germany under a fellowship from the Heinrich Hertz-Stiftung Foundation. She was the 2007 recipient of the Cecil Award for Excellence in Health Policy Research, the 2010 recipient of a Distinguished Service Award from the National Academies, and the 2012 recipient of the Institute of Medicine staff team achievement award (as the team leader).

Deborah Kamin, RN, PhD, joined ASCO in 1998, leading the Society’s work on a wide range of issues of concern to oncology professionals in all practice settings. Prior to joining ASCO she directed health policy and benefit design for the Department of Defense civilian health insurance program, TRICARE, which covers more than 9 million beneficiaries worldwide. Dr. Kamin earned a bachelor’s degree in nursing at the Medical College of Georgia, a master’s degree in management science at the Naval Postgraduate School, and a PhD in health policy at the George Washington University.

Lovell A. Jones, PhD, a member of the Research Faculty in the College of Science & Engineering at Texas A&M University in Corpus Christi previously held the post professor in the Department of Health Disparities Research and Founding Director of the joint UT MD Anderson Cancer Center/University of Houston Dorothy I. Height Center for Health Equity & Evaluation Research. He is now Professor Emeritus in the Department of Health Disparities Research at the University of Texas M.D. Anderson Cancer Center as well as the University of Texas Graduate School of Biomedical Sciences, one of the few individuals to hold such a position at two UT System institutions. He continues to serve on a number of advisory groups and boards that focus on addressing health equity. He has more than 35 years of experience in addressing minority health and the health of the underserved. As a scientist, he has also done extensive research into the relationship between hormones, diet and endocrine responsive tumors and has presented his work both nationally and internationally. He has edited one of the few comprehensive textbooks on this subject: Minorities & Cancer. He has chaired or co-chaired numerous major events regarding the underserved and cancers, including the 1st National African Cancer Education meeting in Abuja, Nigeria. He is co-author of the congressional resolution designating the third full week in April as "National Minority Cancer Awareness Week." For his work, the NIH/National Center on Minority Health and Health Disparities was awarded him its Director’s Award for Excellence in Health Disparities. He has also received the Ruth Kirschstein Diversity in Science Award and was selected as one of the top African American Scientist in America by the National Science Foundation “The History Makers.” In January 2000, he was named the first director of the congressionally mandated Center for Research on Minority Health (CRMH), a multidisciplinary center which aims to a) foster research that addresses the causes of health disparities and translates scientific results back to the communities affected by those disparities; b) encourage minority students to pursue careers in the biomedical sciences; and c) increase recruitment and retention of minority and medically underserved populations into clinical trials.